Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model (Q40309215)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 March 2006

Language	Label	Description	Also known as
English	Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model	scientific article published on 3 March 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Day CP

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Rau KM

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Qiu L

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Liu CW

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Kuo HP

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Xie X

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Lopez-Berestein G

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Hortobagyi GN

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Hung MC

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

3 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

706-719

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Interfaces between the detection, signaling, and repair of DNA damage

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Maintenance of genome stability in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Connecting chromosomes, crisis, and cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Tissue-specific promoters for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Treatment efficiency of a suicide gene therapy using prostate-specific membrane antigen promoter/enhancer in a castrated mouse model of prostate cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Conditional gene targeting for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Enhanced gene expression in breast cancer cells in vitro and tumors in vivo

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Improved DNA: liposome complexes for increased systemic delivery and gene expression

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase IIalpha gene

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Role of intron I in expression of the human factor IX gene

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Distinct roles for cyclin-dependent kinases in cell cycle control

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Retroviral gene therapy: safety issues and possible solutions

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Gene therapy. Viral vectors still pack surprises

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Tumour vasculature--a potential therapeutic target

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases.

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

21 January 2018

In silico comparison of the transcriptome derived from purified normal breast cells and breast tumor cell lines reveals candidate upregulated genes in breast tumor cells

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700945

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700945

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40309215&oldid=2203590699"